APO Research
Talk to an analyst

APO RESEARCH · REPORT

Generic Drugs

A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.

Selected research

Industry Growth & Trends

Global Generic Drugs Industry Growth and Trends Forecast to 2032

1 January 2026124 pages

Choose your research edition.

Industry ResearchGeneric Drugs Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Generic Drugs Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Generic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Generic Drugs Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Generic Drugs Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.

According to APO Research, the global Generic Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Generic Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Generic Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Generic Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Generic Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Generic Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Generic Drugs Market by Company

Teva

Novartis - Sandoz

Mylan

Sun Pharmaceutical

Aspen

Fresenius Kabi

Pfizer (Hospira)

Sanofi

Aurobindo

Lupin

Dr. Reddy's

Apotex

Cipla

ENDO (Par Pharmaceutical)

Stada Arzneimittel

Krka Group

Nichi-Iko Pharmaceutical

Valeant

Zydus Cadila

Hikma

Pharmaniaga Berhad

Hovid Berhad

Duopharma Biotech

Kotra Pharma

HOE Pharmaceutical

Y.S.P. Industries

Generic Drugs Segment by Type

Prescription

Non-Prescription Drugs

Generic Drugs Segment by Application

Hospital

Clinic

Others

Generic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Generic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Generic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Generic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Generic Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Generic Drugs Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Generic Drugs Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Generic Drugs Market Share by Region (2021-2026) Table 4. Global Generic Drugs Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Generic Drugs Market Share by Region (2027-2032) Table 6. Global Generic Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Generic Drugs Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Generic Drugs Market Size Share by Type (2021-2026) Table 9. Global Generic Drugs Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Generic Drugs Market Size Share Forecasted by Type (2027-2032) Table 11. North America Generic Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Generic Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Generic Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Generic Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Generic Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Generic Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Generic Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Generic Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Generic Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Generic Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Generic Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Generic Drugs Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Generic Drugs Market Size Share by Application (2021-2026) Table 24. Global Generic Drugs Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Generic Drugs Market Size Share Forecasted by Application (2027-2032) Table 26. North America Generic Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Generic Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Generic Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Generic Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Generic Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Generic Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Generic Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Generic Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Generic Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Generic Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Generic Drugs Industry Trends Table 37. Generic Drugs Industry Drivers Table 38. Generic Drugs Industry Opportunities and Challenges Table 39. Generic Drugs Industry Restraints Table 40. Global Generic Drugs Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Generic Drugs Revenue Market Share by Company (2021-2026) Table 42. Global Generic Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Generic Drugs Key Company Headquarters & Area Served Table 44. Global Generic Drugs Company, Product Type & Application Table 45. Global Generic Drugs Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Generic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Teva Company Information Table 49. Teva Business Overview Table 50. Teva Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Teva Generic Drugs Product Portfolio Table 52. Teva Recent Development Table 53. Novartis - Sandoz Company Information Table 54. Novartis - Sandoz Business Overview Table 55. Novartis - Sandoz Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Novartis - Sandoz Generic Drugs Product Portfolio Table 57. Novartis - Sandoz Recent Development Table 58. Mylan Company Information Table 59. Mylan Business Overview Table 60. Mylan Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Mylan Generic Drugs Product Portfolio Table 62. Mylan Recent Development Table 63. Sun Pharmaceutical Company Information Table 64. Sun Pharmaceutical Business Overview Table 65. Sun Pharmaceutical Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Sun Pharmaceutical Generic Drugs Product Portfolio Table 67. Sun Pharmaceutical Recent Development Table 68. Aspen Company Information Table 69. Aspen Business Overview Table 70. Aspen Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Aspen Generic Drugs Product Portfolio Table 72. Aspen Recent Development Table 73. Fresenius Kabi Company Information Table 74. Fresenius Kabi Business Overview Table 75. Fresenius Kabi Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Fresenius Kabi Generic Drugs Product Portfolio Table 77. Fresenius Kabi Recent Development Table 78. Pfizer (Hospira) Company Information Table 79. Pfizer (Hospira) Business Overview Table 80. Pfizer (Hospira) Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Pfizer (Hospira) Generic Drugs Product Portfolio Table 82. Pfizer (Hospira) Recent Development Table 83. Sanofi Company Information Table 84. Sanofi Business Overview Table 85. Sanofi Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Sanofi Generic Drugs Product Portfolio Table 87. Sanofi Recent Development Table 88. Aurobindo Company Information Table 89. Aurobindo Business Overview Table 90. Aurobindo Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Aurobindo Generic Drugs Product Portfolio Table 92. Aurobindo Recent Development Table 93. Lupin Company Information Table 94. Lupin Business Overview Table 95. Lupin Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Lupin Generic Drugs Product Portfolio Table 97. Lupin Recent Development Table 98. Dr. Reddy's Company Information Table 99. Dr. Reddy's Business Overview Table 100. Dr. Reddy's Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Dr. Reddy's Generic Drugs Product Portfolio Table 102. Dr. Reddy's Recent Development Table 103. Apotex Company Information Table 104. Apotex Business Overview Table 105. Apotex Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Apotex Generic Drugs Product Portfolio Table 107. Apotex Recent Development Table 108. Cipla Company Information Table 109. Cipla Business Overview Table 110. Cipla Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Cipla Generic Drugs Product Portfolio Table 112. Cipla Recent Development Table 113. ENDO (Par Pharmaceutical) Company Information Table 114. ENDO (Par Pharmaceutical) Business Overview Table 115. ENDO (Par Pharmaceutical) Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. ENDO (Par Pharmaceutical) Generic Drugs Product Portfolio Table 117. ENDO (Par Pharmaceutical) Recent Development Table 118. Stada Arzneimittel Company Information Table 119. Stada Arzneimittel Business Overview Table 120. Stada Arzneimittel Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Stada Arzneimittel Generic Drugs Product Portfolio Table 122. Stada Arzneimittel Recent Development Table 123. Krka Group Company Information Table 124. Krka Group Business Overview Table 125. Krka Group Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Krka Group Generic Drugs Product Portfolio Table 127. Krka Group Recent Development Table 128. Nichi-Iko Pharmaceutical Company Information Table 129. Nichi-Iko Pharmaceutical Business Overview Table 130. Nichi-Iko Pharmaceutical Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Nichi-Iko Pharmaceutical Generic Drugs Product Portfolio Table 132. Nichi-Iko Pharmaceutical Recent Development Table 133. Valeant Company Information Table 134. Valeant Business Overview Table 135. Valeant Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Valeant Generic Drugs Product Portfolio Table 137. Valeant Recent Development Table 138. Zydus Cadila Company Information Table 139. Zydus Cadila Business Overview Table 140. Zydus Cadila Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Zydus Cadila Generic Drugs Product Portfolio Table 142. Zydus Cadila Recent Development Table 143. Hikma Company Information Table 144. Hikma Business Overview Table 145. Hikma Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Hikma Generic Drugs Product Portfolio Table 147. Hikma Recent Development Table 148. Pharmaniaga Berhad Company Information Table 149. Pharmaniaga Berhad Business Overview Table 150. Pharmaniaga Berhad Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Pharmaniaga Berhad Generic Drugs Product Portfolio Table 152. Pharmaniaga Berhad Recent Development Table 153. Hovid Berhad Company Information Table 154. Hovid Berhad Business Overview Table 155. Hovid Berhad Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Hovid Berhad Generic Drugs Product Portfolio Table 157. Hovid Berhad Recent Development Table 158. Duopharma Biotech Company Information Table 159. Duopharma Biotech Business Overview Table 160. Duopharma Biotech Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Duopharma Biotech Generic Drugs Product Portfolio Table 162. Duopharma Biotech Recent Development Table 163. Kotra Pharma Company Information Table 164. Kotra Pharma Business Overview Table 165. Kotra Pharma Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. Kotra Pharma Generic Drugs Product Portfolio Table 167. Kotra Pharma Recent Development Table 168. HOE Pharmaceutical Company Information Table 169. HOE Pharmaceutical Business Overview Table 170. HOE Pharmaceutical Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. HOE Pharmaceutical Generic Drugs Product Portfolio Table 172. HOE Pharmaceutical Recent Development Table 173. Y.S.P. Industries Company Information Table 174. Y.S.P. Industries Business Overview Table 175. Y.S.P. Industries Generic Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 176. Y.S.P. Industries Generic Drugs Product Portfolio Table 177. Y.S.P. Industries Recent Development Table 178. North America Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. North America Generic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 180. North America Generic Drugs Market Share by Country (2021-2026) Table 181. North America Generic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. North America Generic Drugs Market Share Forecast by Country (2027-2032) Table 183. Europe Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Europe Generic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 185. Europe Generic Drugs Market Share by Country (2021-2026) Table 186. Europe Generic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Europe Generic Drugs Market Share Forecast by Country (2027-2032) Table 188. Asia-Pacific Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Asia-Pacific Generic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 190. Asia-Pacific Generic Drugs Market Share by Country (2021-2026) Table 191. Asia-Pacific Generic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Asia-Pacific Generic Drugs Market Share Forecast by Country (2027-2032) Table 193. Latin America Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Latin America Generic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 195. Latin America Generic Drugs Market Share by Country (2021-2026) Table 196. Latin America Generic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Latin America Generic Drugs Market Share Forecast by Country (2027-2032) Table 198. Middle East & Africa Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Middle East & Africa Generic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 200. Middle East & Africa Generic Drugs Market Share by Country (2021-2026) Table 201. Middle East & Africa Generic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Middle East & Africa Generic Drugs Market Share Forecast by Country (2027-2032) Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Generic Drugs Product Image Figure 3. Global Generic Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Generic Drugs Market Size (2021-2032) & (US$ Million) Figure 5. Global Generic Drugs Market Share by Region: 2025 VS 2032 Figure 6. Global Generic Drugs Market Share by Region (2021-2032) Figure 7. North America Generic Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Generic Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Generic Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Generic Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Generic Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Prescription Image Figure 13. Global Prescription Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Non-Prescription Drugs Image Figure 15. Global Non-Prescription Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Generic Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Generic Drugs Market Share by Type 2025 VS 2032 Figure 18. North America Generic Drugs Market Size Share by Type (2021-2032) Figure 19. Europe Generic Drugs Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Generic Drugs Market Size Share by Type (2021-2032) Figure 21. Latin America Generic Drugs Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Generic Drugs Market Size Share by Type (2021-2032) Figure 23. Hospital Image Figure 24. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Clinic Image Figure 26. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Others Image Figure 28. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Generic Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Generic Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Generic Drugs Market Size Share by Application (2021-2032) Figure 32. Europe Generic Drugs Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Generic Drugs Market Size Share by Application (2021-2032) Figure 34. Latin America Generic Drugs Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Generic Drugs Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Generic Drugs Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Generic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Generic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Generic Drugs Market Share by Country (2021-2032) Figure 41. Europe Generic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Generic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Generic Drugs Market Share by Country (2021-2032) Figure 44. Asia-Pacific Generic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Generic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Generic Drugs Market Share by Country (2021-2032) Figure 47. Latin America Generic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Generic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Generic Drugs Market Share by Country (2021-2032) Figure 50. Middle East & Africa Generic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Generic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Generic Drugs Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription
  • Non-Prescription Drugs
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva
  • Novartis - Sandoz
  • Mylan
  • Sun Pharmaceutical
  • Aspen
  • Fresenius Kabi
  • Pfizer (Hospira)
  • Sanofi
  • Aurobindo
  • Lupin
  • Dr. Reddy's
  • Apotex
  • Cipla
  • ENDO (Par Pharmaceutical)
  • Stada Arzneimittel
  • Krka Group
  • Nichi-Iko Pharmaceutical
  • Valeant
  • Zydus Cadila
  • Hikma
  • Pharmaniaga Berhad
  • Hovid Berhad
  • Duopharma Biotech
  • Kotra Pharma
  • HOE Pharmaceutical
  • Y.S.P. Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Generic Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Generic Drugs Market Size by Region (2021-2032)
  5. 1.4.1 Global Generic Drugs Market Size by Region (2021-2026)
  6. 1.4.2 Global Generic Drugs Market Size by Region (2027-2032)
  7. 1.5 Key Regions Generic Drugs Market Size (2021-2032)
  8. 1.5.1 North America Generic Drugs Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Generic Drugs Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Generic Drugs Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Generic Drugs Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Generic Drugs Market Size Growth Rate (2021-2032)
2 Generic Drugs Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Prescription
  3. 2.1.2 Non-Prescription Drugs
  4. 2.2 Global Generic Drugs Market Size by Type
  5. 2.2.1 Global Generic Drugs Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Generic Drugs Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Generic Drugs Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Generic Drugs Market Size by Regions
  9. 2.3.1 North America Generic Drugs Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Generic Drugs Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Generic Drugs Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Generic Drugs Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Generic Drugs Market Size Breakdown by Type (2021-2026)
3 Generic Drugs Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Others
  5. 3.2 Global Generic Drugs Market Size by Application
  6. 3.2.1 Global Generic Drugs Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Generic Drugs Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Generic Drugs Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Generic Drugs Market Size by Regions
  10. 3.3.1 North America Generic Drugs Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Generic Drugs Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Generic Drugs Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Generic Drugs Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Generic Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Generic Drugs Industry Trends
  2. 4.2 Generic Drugs Industry Drivers
  3. 4.3 Generic Drugs Industry Opportunities and Challenges
  4. 4.4 Generic Drugs Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Generic Drugs Revenue (2021-2026)
  2. 5.2 Global Generic Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Generic Drugs Key Company Headquarters & Area Served
  4. 5.4 Global Generic Drugs Company, Product Type & Application
  5. 5.5 Global Generic Drugs Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Generic Drugs Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Generic Drugs Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Generic Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Teva Generic Drugs Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Novartis - Sandoz
  8. 6.2.1 Novartis - Sandoz Company Information
  9. 6.2.2 Novartis - Sandoz Business Overview
  10. 6.2.3 Novartis - Sandoz Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Novartis - Sandoz Generic Drugs Product Portfolio
  12. 6.2.5 Novartis - Sandoz Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Generic Drugs Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Sun Pharmaceutical
  20. 6.4.1 Sun Pharmaceutical Company Information
  21. 6.4.2 Sun Pharmaceutical Business Overview
  22. 6.4.3 Sun Pharmaceutical Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Sun Pharmaceutical Generic Drugs Product Portfolio
  24. 6.4.5 Sun Pharmaceutical Recent Developments
  25. 6.5 Aspen
  26. 6.5.1 Aspen Company Information
  27. 6.5.2 Aspen Business Overview
  28. 6.5.3 Aspen Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Aspen Generic Drugs Product Portfolio
  30. 6.5.5 Aspen Recent Developments
  31. 6.6 Fresenius Kabi
  32. 6.6.1 Fresenius Kabi Company Information
  33. 6.6.2 Fresenius Kabi Business Overview
  34. 6.6.3 Fresenius Kabi Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Fresenius Kabi Generic Drugs Product Portfolio
  36. 6.6.5 Fresenius Kabi Recent Developments
  37. 6.7 Pfizer (Hospira)
  38. 6.7.1 Pfizer (Hospira) Company Information
  39. 6.7.2 Pfizer (Hospira) Business Overview
  40. 6.7.3 Pfizer (Hospira) Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer (Hospira) Generic Drugs Product Portfolio
  42. 6.7.5 Pfizer (Hospira) Recent Developments
  43. 6.8 Sanofi
  44. 6.8.1 Sanofi Company Information
  45. 6.8.2 Sanofi Business Overview
  46. 6.8.3 Sanofi Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Sanofi Generic Drugs Product Portfolio
  48. 6.8.5 Sanofi Recent Developments
  49. 6.9 Aurobindo
  50. 6.9.1 Aurobindo Company Information
  51. 6.9.2 Aurobindo Business Overview
  52. 6.9.3 Aurobindo Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Aurobindo Generic Drugs Product Portfolio
  54. 6.9.5 Aurobindo Recent Developments
  55. 6.10 Lupin
  56. 6.10.1 Lupin Company Information
  57. 6.10.2 Lupin Business Overview
  58. 6.10.3 Lupin Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Lupin Generic Drugs Product Portfolio
  60. 6.10.5 Lupin Recent Developments
  61. 6.11 Dr. Reddy's
  62. 6.11.1 Dr. Reddy's Company Information
  63. 6.11.2 Dr. Reddy's Business Overview
  64. 6.11.3 Dr. Reddy's Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Dr. Reddy's Generic Drugs Product Portfolio
  66. 6.11.5 Dr. Reddy's Recent Developments
  67. 6.12 Apotex
  68. 6.12.1 Apotex Company Information
  69. 6.12.2 Apotex Business Overview
  70. 6.12.3 Apotex Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Apotex Generic Drugs Product Portfolio
  72. 6.12.5 Apotex Recent Developments
  73. 6.13 Cipla
  74. 6.13.1 Cipla Company Information
  75. 6.13.2 Cipla Business Overview
  76. 6.13.3 Cipla Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Cipla Generic Drugs Product Portfolio
  78. 6.13.5 Cipla Recent Developments
  79. 6.14 ENDO (Par Pharmaceutical)
  80. 6.14.1 ENDO (Par Pharmaceutical) Company Information
  81. 6.14.2 ENDO (Par Pharmaceutical) Business Overview
  82. 6.14.3 ENDO (Par Pharmaceutical) Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 ENDO (Par Pharmaceutical) Generic Drugs Product Portfolio
  84. 6.14.5 ENDO (Par Pharmaceutical) Recent Developments
  85. 6.15 Stada Arzneimittel
  86. 6.15.1 Stada Arzneimittel Company Information
  87. 6.15.2 Stada Arzneimittel Business Overview
  88. 6.15.3 Stada Arzneimittel Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Stada Arzneimittel Generic Drugs Product Portfolio
  90. 6.15.5 Stada Arzneimittel Recent Developments
  91. 6.16 Krka Group
  92. 6.16.1 Krka Group Company Information
  93. 6.16.2 Krka Group Business Overview
  94. 6.16.3 Krka Group Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Krka Group Generic Drugs Product Portfolio
  96. 6.16.5 Krka Group Recent Developments
  97. 6.17 Nichi-Iko Pharmaceutical
  98. 6.17.1 Nichi-Iko Pharmaceutical Company Information
  99. 6.17.2 Nichi-Iko Pharmaceutical Business Overview
  100. 6.17.3 Nichi-Iko Pharmaceutical Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Nichi-Iko Pharmaceutical Generic Drugs Product Portfolio
  102. 6.17.5 Nichi-Iko Pharmaceutical Recent Developments
  103. 6.18 Valeant
  104. 6.18.1 Valeant Company Information
  105. 6.18.2 Valeant Business Overview
  106. 6.18.3 Valeant Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Valeant Generic Drugs Product Portfolio
  108. 6.18.5 Valeant Recent Developments
  109. 6.19 Zydus Cadila
  110. 6.19.1 Zydus Cadila Company Information
  111. 6.19.2 Zydus Cadila Business Overview
  112. 6.19.3 Zydus Cadila Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Zydus Cadila Generic Drugs Product Portfolio
  114. 6.19.5 Zydus Cadila Recent Developments
  115. 6.20 Hikma
  116. 6.20.1 Hikma Company Information
  117. 6.20.2 Hikma Business Overview
  118. 6.20.3 Hikma Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Hikma Generic Drugs Product Portfolio
  120. 6.20.5 Hikma Recent Developments
  121. 6.21 Pharmaniaga Berhad
  122. 6.21.1 Pharmaniaga Berhad Company Information
  123. 6.21.2 Pharmaniaga Berhad Business Overview
  124. 6.21.3 Pharmaniaga Berhad Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Pharmaniaga Berhad Generic Drugs Product Portfolio
  126. 6.21.5 Pharmaniaga Berhad Recent Developments
  127. 6.22 Hovid Berhad
  128. 6.22.1 Hovid Berhad Company Information
  129. 6.22.2 Hovid Berhad Business Overview
  130. 6.22.3 Hovid Berhad Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Hovid Berhad Generic Drugs Product Portfolio
  132. 6.22.5 Hovid Berhad Recent Developments
  133. 6.23 Duopharma Biotech
  134. 6.23.1 Duopharma Biotech Company Information
  135. 6.23.2 Duopharma Biotech Business Overview
  136. 6.23.3 Duopharma Biotech Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Duopharma Biotech Generic Drugs Product Portfolio
  138. 6.23.5 Duopharma Biotech Recent Developments
  139. 6.24 Kotra Pharma
  140. 6.24.1 Kotra Pharma Company Information
  141. 6.24.2 Kotra Pharma Business Overview
  142. 6.24.3 Kotra Pharma Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 Kotra Pharma Generic Drugs Product Portfolio
  144. 6.24.5 Kotra Pharma Recent Developments
  145. 6.25 HOE Pharmaceutical
  146. 6.25.1 HOE Pharmaceutical Company Information
  147. 6.25.2 HOE Pharmaceutical Business Overview
  148. 6.25.3 HOE Pharmaceutical Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 HOE Pharmaceutical Generic Drugs Product Portfolio
  150. 6.25.5 HOE Pharmaceutical Recent Developments
  151. 6.26 Y.S.P. Industries
  152. 6.26.1 Y.S.P. Industries Company Information
  153. 6.26.2 Y.S.P. Industries Business Overview
  154. 6.26.3 Y.S.P. Industries Generic Drugs Revenue, Global Share and Gross Margin (2021-2026)
  155. 6.26.4 Y.S.P. Industries Generic Drugs Product Portfolio
  156. 6.26.5 Y.S.P. Industries Recent Developments
7 North America
  1. 7.1 North America Generic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Generic Drugs Market Size by Country (2021-2026)
  3. 7.3 North America Generic Drugs Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Generic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Generic Drugs Market Size by Country (2021-2026)
  3. 8.3 Europe Generic Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Generic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Generic Drugs Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Generic Drugs Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Generic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Generic Drugs Market Size by Country (2021-2026)
  3. 10.3 South America Generic Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Generic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Generic Drugs Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Generic Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst